No preventive effects of 23-valent pneumococcal polysaccharide vaccine in patients with chronic renal failure

被引：5
|
作者：
Hsieh, Meng-Jer
Yu, Chun-Chen
Hu, Han-Chung
Thai, Ying-Huang
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2016年 / 48卷
关键词：
Pneumonia; Vaccination; Chronic disease;
D O I：
10.1183/13993003.congress-2016.PA612
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA612
引用
收藏
页数：2
相关论文
共 50 条
  • [21] PHARMACOECONOMIC EVALUATION OF 13-VALENT PNEUMOCOCCAL CONJUGATE AND 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN CANADIAN ADULTS
    Chuck, A.
    Waye, A.
    Zanotti, G.
    Jacobs, P.
    Kellner, J.
    Tyrrell, G.
    VALUE IN HEALTH, 2012, 15 (04) : A243 - A243
  • [22] Cardiovascular, Neurological, and Immunological Adverse Events and the 23-Valent Pneumococcal Polysaccharide Vaccine
    Yoon, Dongwon
    Jeon, Ha-Lim
    Kim, Ju Hwan
    Lee, Hyesung
    Shin, Ju-Young
    JAMA NETWORK OPEN, 2024, 7 (01) : E2352597
  • [23] Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients
    Breiman, RF
    Keller, DW
    Phelan, MA
    Sniadack, DH
    Stephens, DS
    Rimland, D
    Farley, MM
    Schuchat, A
    Reingold, AL
    ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (17) : 2633 - 2638
  • [24] TOLERABILITY AND SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC VASCULITIS, PRELIMINARY RESULTS
    Tarasova, G.
    Egorova, O.
    Reshetnyak, T.
    Belov, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1435 - 1435
  • [25] TOLERABILITY AND SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME, PRELIMINARY RESULTS
    Tarasova, G.
    Belov, B.
    Cherkasova, M.
    Aseeva, E.
    Reshetnyak, T.
    Kosheleva, N.
    Popkova, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1180 - 1181
  • [26] 23-valent pneumococcal polysaccharide vaccine improves survival in dialysis patients by preventing cardiac events
    Ihara, Hiroaki
    Kikuchi, Kan
    Taniguchi, Hiromi
    Fujita, Shogo
    Tsuruta, Yuki
    Kato, Motoyasu
    Mitsuishi, Yoichiro
    Tajima, Ken
    Kodama, Yuzo
    Takahashi, Fumiyuki
    Takahashi, Kazuhisa
    Azuma, Nakanobu
    VACCINE, 2019, 37 (43) : 6447 - 6453
  • [27] Failure to vaccinate or failure of vaccine? Effectiveness of the 23-valent pneumococcal polysaccharide vaccine program in Indigenous adults in the Northern Territory of Australia
    Moberley, S.
    Krause, V.
    Cook, H.
    Mulholland, K.
    Carapetis, J.
    Torzillo, P.
    Andrews, R.
    VACCINE, 2010, 28 (11) : 2296 - 2301
  • [28] Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in Navajo adults
    Benin, A
    O'Brien, K
    Watt, J
    Reid, R
    Zell, ER
    Katz, S
    Donaldson, C
    Parkinson, A
    Schuchat, A
    Santosham, M
    Whitney, CG
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1148 - 1148
  • [29] Safety of 23-Valent Pneumococcal Vaccine in Rheumatoid Arthritis Patients
    Naumtseva, Marina S.
    Belov, Boris S.
    Tarasova, Galina M.
    Karateev, Dmitriy E.
    Luchikina, Elena E.
    Muravyev, Yury V.
    Alexandrova, Elena N.
    Novikov, Alexander A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S21 - S21
  • [30] SAFETY AND IMMUNOGENICITY OF 23-VALENT PNEUMOCOCCAL VACCINE IN SLE PATIENTS
    Tarasova, G.
    Belov, B.
    Bukhanova, D.
    Soloviev, S.
    Aseeva, E.
    Popkova, T.
    Cherkasova, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1061 - 1061
12345